Avaí Bio Logo
  • Home
  • Diabetes
  • Klotho
  • Cell Encapsulation
  • Investor Relations
  • Contact
Avaí Bio Logo
  • Overview
  • News / Events
    • Press Releases
    • IR Calendar
    • Email Alerts
  • Company Information
    • Management Team
    • Contacts
    • FAQ
  • Presentations
  • Stock Data
    • Quote
    • Charts
    • Historical Data
  • SEC Filings
    • All SEC Filings
    • Annual Reports
    • Quarterly Reports
    • Section 16 Filings
  • Corporate Governance
    • Board of Directors
Avaí Bio Logo
  • Home
  • Diabetes
  • Klotho
  • Cell Encapsulation
  • Investor Relations
  • Contact

Press Releases

 

Navigation
  • Overview
  • News / Events
    • Press Releases
    • IR Calendar
    • Email Alerts
  • Company Information
    • Management Team
    • Contacts
    • FAQ
  • Presentations
  • Stock Data
    • Quote
    • Charts
    • Historical Data
  • SEC Filings
    • All SEC Filings
    • Annual Reports
    • Quarterly Reports
    • Section 16 Filings
  • Corporate Governance
    • Board of Directors
  • Quick Links
  • Email Alerts
  • Contacts
  • RSS News Feed
  • All News
  • 2026
  • 2025
  • 2024
  • 2023
  • 2022

Avai Bio, Inc. Issues Retraction of September 24, 2025 Press Release

Sep 24, 2025

Global Cell Therapy Market Size Expected to Reach $44 Billion as Demand for Regenerative Medicine Rises

Sep 18, 2025

Avai Bio and Austrianova Sign Joint Venture, Licensing Agreement to Advance Klotho-Based Therapies

Sep 18, 2025

Avai Bio and Ainnova Tech Announce Enhanced Patient Recruitment Strategy Ahead of FDA Clinical Trial

Aug 12, 2025

Avai Bio and Ainnova Tech Advance Clinical Trial Protocol Following FDA Feedback

Jul 29, 2025

Avai Bio and Ainnova Tech Advance Clinical Trial Protocol Following FDA Feedback

Jul 29, 2025

Artificial Intelligence Influence in Ophthalmology Industry Projected to Create a Billion Dollar Revenue Opportunity

Jul 22, 2025

Avai Bio' Joint Venture Partner Presents AI Technology at Roche Ophthalmology Conference

Jul 22, 2025

Artificial Intelligence Revolutionizing Early Detection of Diabetic Retinopathy Creating a Multi-Billion Dollar Revenue Opportunity

Jul 15, 2025

Avai Bio and JV Partner, Ainnova, Complete Pivotal Meeting with U.S. FDA

Jul 15, 2025

RSS
« First « Previous 1 2 3 4 5 6 7 8 9 10 11 12 13 Next » Last »
Avai Bio

Contact Us

Call: 866.533.0065

Fax: 702.872.2060

info@avaibio.com

Company

Diabetes Klotho Cell Encapsulation Investor Relations

Copyright © 2026 Avaí Bio, Inc. All rights reserved.

Spyr
Powered by  GDPR Cookie Compliance
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.

Strictly Necessary Cookies

Strictly Necessary Cookie should be enabled at all times so that we can save your preferences for cookie settings.

If you disable this cookie, we will not be able to save your preferences. This means that every time you visit this website you will need to enable or disable cookies again.